Changes in Food Buying Habits After Starting a Glucagon-Like Peptide-1 Receptor Agonist

Conflict of Interest Disclosures: Dr Hasselbalch reported receiving grants from the Novo Nordisk Foundation as a part of the BRIDGE Translational Excellence Programme during the conduct of the study. Dr Torp-Pedersen reported receiving grants from Bayer and Novo Nordisk outside the submitted work. No other disclosures were reported.